Our research team has previously demonstrated that RRS1 expression was linked to a poor prognosis in BC and might promote the proliferation of BC cells via ribosomal protein L11 (RPL11)/murine double minute 2 (MDM2)-mediated p53 activation [10]. This evidence concerns the gene TP53 and breast cancer.